US20140262858A1 - Packaging for alitretinoin - Google Patents

Packaging for alitretinoin Download PDF

Info

Publication number
US20140262858A1
US20140262858A1 US14/351,928 US201214351928A US2014262858A1 US 20140262858 A1 US20140262858 A1 US 20140262858A1 US 201214351928 A US201214351928 A US 201214351928A US 2014262858 A1 US2014262858 A1 US 2014262858A1
Authority
US
United States
Prior art keywords
alitretinoin
vacuum
oxygen absorber
bag
oxygen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/351,928
Other languages
English (en)
Inventor
Suresh Babu Jayachandra
Tarun Kumar Singh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sun Pharmaceutical Industries Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Assigned to RANBAXY LABORATORIES LIMITED reassignment RANBAXY LABORATORIES LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: JAYACHANDRA, SURESH BABU, SINGH, TARUN KUMAR
Publication of US20140262858A1 publication Critical patent/US20140262858A1/en
Assigned to SUN PHARMACEUTICAL INDUSTRIES LIMITED reassignment SUN PHARMACEUTICAL INDUSTRIES LIMITED MERGER (SEE DOCUMENT FOR DETAILS). Assignors: RANBAXY LABORATORIES LIMTED
Abandoned legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D81/00Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
    • B65D81/24Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants
    • B65D81/26Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants with provision for draining away, or absorbing, or removing by ventilation, fluids, e.g. exuded by contents; Applications of corrosion inhibitors or desiccators
    • B65D81/266Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants with provision for draining away, or absorbing, or removing by ventilation, fluids, e.g. exuded by contents; Applications of corrosion inhibitors or desiccators for absorbing gases, e.g. oxygen absorbers or desiccants
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D77/00Packages formed by enclosing articles or materials in preformed containers, e.g. boxes, cartons, sacks or bags
    • B65D77/04Articles or materials enclosed in two or more containers disposed one within another
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D81/00Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
    • B65D81/18Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient
    • B65D81/20Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient under vacuum or superatmospheric pressure, or in a special atmosphere, e.g. of inert gas
    • B65D81/2007Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient under vacuum or superatmospheric pressure, or in a special atmosphere, e.g. of inert gas under vacuum
    • B65D81/2023Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient under vacuum or superatmospheric pressure, or in a special atmosphere, e.g. of inert gas under vacuum in a flexible container
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D81/00Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
    • B65D81/18Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient
    • B65D81/20Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient under vacuum or superatmospheric pressure, or in a special atmosphere, e.g. of inert gas
    • B65D81/2069Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient under vacuum or superatmospheric pressure, or in a special atmosphere, e.g. of inert gas in a special atmosphere
    • B65D81/2084Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient under vacuum or superatmospheric pressure, or in a special atmosphere, e.g. of inert gas in a special atmosphere in a flexible container

Definitions

  • the present invention relates to the use of an oxygen absorber and silica gel desiccant in a vacuum-sealed pack for the reduction or prevention of oxidative degradation of alitretinoin.
  • Alitretinoin is a first generation retinoid.
  • the chemical name of alitretinoin is 9-cis retinoic acid or (2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-2,4,6,8-nonatraenoic acid and the structural formula is as follows:
  • Japanese Patent No. JP 59-176247 discloses a method for preventing the decomposition of water-soluble azunole of Formula II
  • U.S. Pat. No. 6,007,529 discloses a flexible transparent container for the improved storage of oxygen sensitive parenterally administrable agents that is comprised of an inner primary container that is enclosed in an oxygen impermeable outer envelope with an oxygen absorber capable of consuming all residual oxygen after the outer envelope is sealed.
  • PCT Publication No. WO 2006/008651 discloses a package to protect pharmaceuticals, e.g., atorvastatin, which comprises a bottle, a desiccant disposed within the first sub-container, and a self-activated metal based oxygen absorber disposed within the second sub-container.
  • U.S. Publication No. 2005/0268573 relates to a method for packaging a sterile article that comprises providing a container; placing the article into the interior of the container; exposing the permeable portion of the container to the exterior environment; and removing the sterilizing gas.
  • U.S. Publication No. 2009/0071855 discloses a vacuum-sealed pack comprising an amorphous statin or a pharmaceutical composition thereof and at least one stabilizer, for example, an oxygen absorber, a moisture absorber, or a combination thereof.
  • a method for the reduction or prevention of oxidative degradation of alitretinoin using an oxygen absorber and a silica gel desiccant in a vacuum-sealed pack is provided.
  • a vacuum-sealed pack comprising alitretinoin, an oxygen absorber and a silica gel desiccant.
  • a vacuum-sealed pack comprising a pharmaceutical composition comprising alitretinoin, an oxygen absorber, and a silica gel desiccant.
  • a method for the reduction or prevention of oxidative degradation of alitretinoin comprising an oxygen absorber and a silica gel desiccant in a vacuum-sealed pack.
  • a vacuum-sealed pack comprising alitretinoin, an oxygen absorber and a silica gel desiccant.
  • a vacuum-sealed pack which includes a pharmaceutical composition comprising alitretinoin, an oxygen absorber, and a silica gel desiccant.
  • vacuum-sealed pack refers to a low density polyethylene (LDPE) bag that is twisted and tied with a plastic fastener under nitrogen. This bag is packed into a middle bag of polyester/LDPE, a vacuum is applied to the middle bag, and it is heat sealed. The sealed middle bag is packed into a polyester/aluminum/polyester/LDPE bag. Vacuum is applied to the polyester/aluminum/polyester/LDPE bag and it is then heat sealed.
  • LDPE low density polyethylene
  • oxygen absorber is a material capable of absorbing oxygen from the surrounding atmosphere.
  • Oxygen absorbers can be inorganic metal based oxygen absorbers; ascorbic acid based absorbers; enzymatic absorbers; or polymer based oxygen absorbers. Examples of specific oxygen absorbers include, but are not limited to, O-Buster®, FreshPax®, Ageless®, StabilOx® or ZPTJTM.
  • Stability studies of alitretinoin were conducted by loading alitretinoin samples at various stability conditions, for example, at 25 ⁇ 2° C./60 ⁇ 5% relative humidity (RH) and 40 ⁇ 2° C./75 ⁇ 5% RH in the absence or presence of an oxygen absorber and a silica desiccant for 1 month, 2 months, 3 months, or 6 months.
  • the stability studies were performed on a stability incubator (for accelerated stability studies, Hotpack was used and for real time stability studies, NuAire® was used).
  • the degradation products were identified using an Agilent® 1100 series HPLC system.
  • the “pharmaceutical composition”, as used herein, includes both capsule and gel forms.
  • Alitretinoin was packed in a LDPE bag.
  • the bag was twisted and tied with a plastic fastener under nitrogen.
  • the LDPE bag was placed into a middle bag of polyester/LDPE and vacuum was applied to the middle bag and then it was heat sealed.
  • the sealed middle bag was packed into a polyester/aluminum/polyester/LDPE bag. Vacuum was applied to this bag and then it was heat sealed.
  • the vacuum-sealed pack was loaded on stability at stations 40 ⁇ 2° C. and 75 ⁇ 5% RH (accelerated) and 25 ⁇ 2° C. and 60 ⁇ 5% RH. The results are presented in Table 1.
  • Alitretinoin was packed in a LDPE bag.
  • the bag was twisted and tied with a plastic fastener under nitrogen.
  • the LDPE bag was placed into a middle bag of polyester/LDPE along with an oxygen absorber.
  • a vacuum was applied to the middle bag and then it was heat sealed.
  • the sealed middle bag was packed into a polyester/aluminum/polyester/LDPE bag along with silica gel as a desiccant. Vacuum was applied to this bag and it was then heat sealed.
  • the vacuum-sealed pack was loaded on stability at 25 ⁇ 2° C. and 60 ⁇ 5% RH. The results are presented in Table 2.
  • Alitretinoin was packed in a LDPE bag; the bag was twisted and tied with a plastic fastener under nitrogen. It was placed into a middle bag of polyester/LDPE along with an oxygen absorber. Vacuum was applied to the middle bag and then it was heat sealed. This sealed middle bag was packed into a polyester/aluminum/polyester/LDPE bag along with silica gel as a desiccant. Vacuum was applied to this bag and then it was heat sealed. The vacuum-sealed pack was loaded on stability at 40 ⁇ 2° C. and 75 ⁇ 5% RH. The results are presented in Table 3.

Landscapes

  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Food Science & Technology (AREA)
  • Packages (AREA)
  • Drying Of Gases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
US14/351,928 2011-10-21 2012-10-19 Packaging for alitretinoin Abandoned US20140262858A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN3019DE2011 2011-10-21
IN3019/DEL/2011 2011-10-21
PCT/IB2012/055762 WO2013057724A1 (fr) 2011-10-21 2012-10-19 Emballage pour alitrétinoïne

Publications (1)

Publication Number Publication Date
US20140262858A1 true US20140262858A1 (en) 2014-09-18

Family

ID=47278918

Family Applications (1)

Application Number Title Priority Date Filing Date
US14/351,928 Abandoned US20140262858A1 (en) 2011-10-21 2012-10-19 Packaging for alitretinoin

Country Status (2)

Country Link
US (1) US20140262858A1 (fr)
WO (1) WO2013057724A1 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5414049A (en) * 1993-06-01 1995-05-09 Howmedica Inc. Non-oxidizing polymeric medical implant
US20090071855A1 (en) * 2007-09-14 2009-03-19 Bahuguna Sumit Packaging for amorphous statins and compositions thereof
US20130015204A1 (en) * 2009-12-24 2013-01-17 Arash Gol Single-use containers and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59176247A (ja) 1983-03-28 1984-10-05 Taiyo Yakuhin Kogyo Kk 水溶性アズノ−ルの分解防止方法
SE9601348D0 (sv) 1996-04-10 1996-04-10 Pharmacia Ab Improved containers for parenteral fluids
US20050268573A1 (en) 2004-01-20 2005-12-08 Avantec Vascular Corporation Package of sensitive articles
WO2006008651A1 (fr) 2004-07-16 2006-01-26 Pfizer Products Inc. Emballage pharmaceutique permettant de maintenir simultanement un faible taux d'humidite et un faible taux d'oxygene
WO2009024946A1 (fr) * 2007-08-21 2009-02-26 Ranbaxy Laboratories Limited Kit d'emballage comprenant un médicament sensible à la lumière, à l'humidité et/ou à l'oxygène
JP4466756B2 (ja) * 2008-04-02 2010-05-26 住友電気工業株式会社 化合物半導体基板の包装方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5414049A (en) * 1993-06-01 1995-05-09 Howmedica Inc. Non-oxidizing polymeric medical implant
US20090071855A1 (en) * 2007-09-14 2009-03-19 Bahuguna Sumit Packaging for amorphous statins and compositions thereof
US20130015204A1 (en) * 2009-12-24 2013-01-17 Arash Gol Single-use containers and uses thereof

Also Published As

Publication number Publication date
WO2013057724A1 (fr) 2013-04-25

Similar Documents

Publication Publication Date Title
US20020132359A1 (en) Dispensing unit for oxygen-sensitive drugs
ES2695158T3 (es) Sistema de envasado para fármacos sensibles al oxígeno
US20160107796A1 (en) Container for the storage, preservation, identification, tracking and transport of a federally controlled substance
ES2567068T3 (es) Enema con irritación reducida para el tratamiento de la enfermedad intestinal inflamatoria (EII)
US20070163917A1 (en) Package and device for simultaneously maintaining low moisture and low oxygen levels
US10869867B2 (en) Intravenous infusion dosage form
RU2011125316A (ru) Твердые лекарственные формы суфентанила, содержащие поглотители кислорода, и способы их применения
US9908682B2 (en) Storage of ampoules containing pharmaceutical formulations using a sealed container comprising an oxygen scavenger
KR20070100720A (ko) 임의로 산소 스캐빈저를 포함하는 산소-불투과성 포장,안정화된 갑상선 호르몬 조성물 및 갑상선 호르몬 약제학적조성물의 보관 방법
MY165840A (en) A storing package unit and a storing method for micro solder spheres
CN103842265A (zh) 用于延长保存的改进的皮氏培养皿扁平包装及其生产方法
US20170233124A1 (en) Method and device for packaging elastomer parts
US20140262858A1 (en) Packaging for alitretinoin
BR112014027885B1 (pt) Processo para a preparação de um pó a granel de brinzolamida estéril
CN111712238A (zh) 含有2-氨基-3-(4-溴苯甲酰基)苯乙酸或其盐的滴眼剂
US20080317859A1 (en) Stabilization of Testosterone Within Transdermal Devices
Akala Effect of packaging on stability of drugs and drug products
Swaroop et al. A glimpse on expiry date of pharmaceutical dosage forms
CN205633649U (zh) 高密封药品包装箱结构
Colgan et al. Use of activated carbon in packaging to attenuate formaldehyde-induced and formic acid–induced degradation and reduce gelatin cross-linking in solid dosage forms
US20040118802A1 (en) Safety seal for potent product
JP2022148904A (ja) 液状製剤及び液状製剤入り製剤容器
WO2022203029A1 (fr) Récipient combiné contenant un liquide, ensemble récipient, et procédé de fabrication pour un récipient contenant un liquide
Turdieva et al. STUDYING STORAGE CONDITIONS AND EXPIRATION DATES SEDTAB TABLETS
Yong et al. Transparent Plastic Envelope for Dispensing Antibiotics-The Best Option in the Market?

Legal Events

Date Code Title Description
AS Assignment

Owner name: RANBAXY LABORATORIES LIMITED, INDIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:JAYACHANDRA, SURESH BABU;SINGH, TARUN KUMAR;REEL/FRAME:032687/0946

Effective date: 20121213

AS Assignment

Owner name: SUN PHARMACEUTICAL INDUSTRIES LIMITED, INDIA

Free format text: MERGER;ASSIGNOR:RANBAXY LABORATORIES LIMTED;REEL/FRAME:037513/0475

Effective date: 20150324

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION